Orthostatic Hypotension Overview
Learn About Orthostatic Hypotension
Orthostatic hypotension is a drop in blood pressure that occurs when moving from a laying down (supine) position to a standing (upright) position. The word "orthostasis" means to stand up, so the condition is defined as low blood pressure (hypotension) that occurs upon standing.
Orthostatic hypotension has two forms that result from two main causes.
Orthostatic hypotension is a common condition that affects about 6 percent of the population. This condition is especially common in older adults, affecting at least 10 to 30 percent of people in this group.
Orthostatic hypotension is a complex condition and is usually not inherited. However, having a close relative with orthostatic hypotension likely increases a person's risk of developing the condition.
Heart Care Centers Of Illinois, S.C.
Charles Kinder is a Cardiac Electrophysiologist and a Cardiologist in Blue Island, Illinois. Dr. Kinder and is rated as an Experienced provider by MediFind in the treatment of Orthostatic Hypotension. His top areas of expertise are Cardiomyopathy, Arrhythmias, Fainting, Pacemaker Implantation, and Cardiac Ablation. Dr. Kinder is currently accepting new patients.
Heart Care Centers Of Illinois, S.C.
Joseph Stella is an Interventional Cardiologist and a Cardiologist in Blue Island, Illinois. Dr. Stella and is rated as an Experienced provider by MediFind in the treatment of Orthostatic Hypotension. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, Necrosis, and Heart Bypass Surgery. Dr. Stella is currently accepting new patients.
Heart Care Centers Of Illinois, S.C.
Robert Iaffaldano is an Interventional Cardiologist and a Cardiologist in Blue Island, Illinois. Dr. Iaffaldano and is rated as an Experienced provider by MediFind in the treatment of Orthostatic Hypotension. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Necrosis, and Thoracic Aortic Aneurysm. Dr. Iaffaldano is currently accepting new patients.
Summary: This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and symptomatic nOH after 20 weeks of treatment. This study includes 4 periods: Screening, open label, randomized withdrawal, and long-term treatment extension (LTE).
Summary: The investigators aim to study which measurements/definitions from continuous blood pressures measurements (using a Finometer) and from cerebral oxygenation measurements (using near-infrared spectroscopy (NIRS)) are associated with future fall incidents in older adults at risk of falls.
Published Date: March 01, 2019
Published By: National Institutes of Health